| abstract |
Compounds effective as IP receptor modulators, in particular IP receptor antagonists, of formula I, wherein A, R 1 and R 2 are as defined herein; and individual isomers thereof Racemic or non-racemic mixtures of isomers and pharmaceutically acceptable salts or solvates. Also disclosed are pharmaceutical compositions containing such compounds and methods for their use as therapeutic agents. |